44. RESULT OF NUTRITIONAL CARE FOR LUNG TRANSPLANT PATIENT: CLINICAL CASE REPORT AT NATIONAL LUNG HOSPITAL IN 2024

Nguyen Quang Dung1,2, Vu Trung Nghia1, Ha Thu Thuy1, Dao Thu Trang1, Chu Hai Dang1, Tran Thi Thu Huyen1, Pham Thi Trang1, Pham Thi Mai Ngoc1, Bui Quynh Hoa1
1 National Lung Hospital
2 Hanoi Medical University

Main Article Content

Abstract

Lung transplantation is an effective treatment for people with end-stage respiratory diseases. Lymphangioleiomyomatosis (LAM) is a rare cancer that involves the formation of air cysts that cause pneumothorax, impaired respiratory function, and also causes tumors in the abdomen and lymph nodes. LAM patients often have poor diagnosis, there is no specific treatment and only palliative treatment support, improving quality of life. We report a case of a female patient, 21 years old, with a historic diagnosis of LAM in 2021, removed a half of the left kidney in 2016 by surgery. Patients receive intensive care and treatment in a sterile area. After 7 weeks, the patient's health condition improved, good nutritional status, normal movement, was discharged from the hospital for outpatient treatment, and was able to adapt with daily life.

Article Details

References

[1] Valapour M, Lehr CJ, Skeans MA, et al. OPTN/
SRTR 2016 Annual Data Report: Lung. American
Journal of Transplantation. 2018;18:363-
433. doi:10.1111/ajt.14562
[2] Harknett EC, Chang WYC, Byrnes S, et al.
Use of variability in national and regional data
to estimate the prevalence of lymphangioleiomyomatosis.
QJM: An International Journal of Medicine. 2011;
104(11):971-979. doi:10.1093/qjmed/hcr116
[3] Johnson S, Whale C, Hubbard R, Lewis S, Tattersfield
A. Survival and disease progression in UK patients with
lymphangioleiomyomatosis. Thorax. 2004;59(9):800-803.
doi:10.1136/thx.2004.023283
[4] Weijs PJM, Kruizenga HM, Van Dijk AE, et al.
Validation of predictive equations for resting energy
expenditure in adult outpatients and inpatients. Clinical
Nutrition. 2008;27(1):150-157.doi:10.1016/j.clnu.2007.09.001
[5] Tynan C, Hasse JM. Current Nutrition Practices in Adult
Lung Transplantation. Nutrition in Clinical Practice. 2004;
19(6):587-596.doi:10.1177/0115426504019006587
[6] Jomphe V, Lands LC, Mailhot G. Nutritional Requirements
of Lung Transplant Recipients: Challenges and Considerations.
Nutrients. 2018;10(6):790. doi:10.3390/nu10060790
[7] González-Castro A, Llorca J, Suberviola B,
Díaz-Regañón G, Ordóñez J, Miñambres E.
Influence of Nutritional Status in Lung Transplant Recipients.
Transplantation Proceedings. 2006;38(8):2539-2540.
doi:10.1016/j.transproceed.2006.08.084
[8] Heidari Z, Nikbakht M, Mashhadi MA, et al.
Vitamin D Deficiency Associated with Differentiated
Thyroid Carcinoma: A Case- Control Study. Asian Pac
J Cancer Prev. 2017;18(12).doi:10.22034/APJCP.2017.
18.12.3419
[9] Hsieh YC, Chiu CL, Yang MF. Nutrition Support of
Malnourished and Severe Vitamin D Deficiency in a
Lung Transplant Recipient: A Case
Report. In: C53. CRITICAL CARE GASTROENTEROLOGY:
CASES. American Thoracic Society; 2023:A5325-A5325.
doi:10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.
A5325
[10] Khanna S, Pardi DS. Clostridium difficile infection:
management strategies for a difficult disease. Therap
Adv Gastroenterol. 2014;7(2):72-86. doi:10.1177/1756283X13508519